In MDR, cancer cells display a broad cross-resistance to unrelated drugs by virtue of the overexpression of the efflux transporters P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1). This evidence concerns the gene CD9 and cancer.